Birdwatch Note
2023-01-22 20:04:19 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Randomized clinical trials and real-world studies have reported the efficacy of the first (mRNA) COVID-19 vaccines after they became available in 2020. In fact, these vaccines were associated with 97% efficacy in preventing severe illness and deaths due to COVID-19. https://www.news-medical.net/amp/news/20221222/Bivalent-mRNA-vaccine-is-moderately-effective-in-preventing-COVID-19.aspx
Written by 98D8319CF00FF86895E7E8055E5BC6976E94DBD9AA49EDD7F395F81FB2F9AC2D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1617054317894328321
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1617251837865857029
- noteId - 1617251837865857029
- participantId - 98D8319CF00FF86895E7E8055E5BC6976E94DBD9AA49EDD7F395F81FB2F9AC2D
- noteAuthorParticipantId -
- createdAtMillis - 1674417859890
- tweetId - 1617054317894328321
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Randomized clinical trials and real-world studies have reported the efficacy of the first (mRNA) COVID-19 vaccines after they became available in 2020. In fact, these vaccines were associated with 97% efficacy in preventing severe illness and deaths due to COVID-19. https://www.news-medical.net/amp/news/20221222/Bivalent-mRNA-vaccine-is-moderately-effective-in-preventing-COVID-19.aspx
Note Ratings
| rated at | rated by | |
| 2023-01-22 22:46:17 -0600 | 02BEA271AF3CAF7D8B8AE277B36C2B7CC08A7561F2E8D69820A8AB7D7CFE6745 | Rating Details |
| 2023-01-23 01:31:50 -0600 | 02CCF82457E901B84A71BEC0022821433A74F2D1B5136B28CA1157657B870C89 | Rating Details |
| 2023-01-23 10:07:10 -0600 | 0415710CFDD825231D330458E74370ABE9499C24330CFCC3A987ACF952D350D0 | Rating Details |
| 2023-01-23 06:02:52 -0600 | 058E73985260F77C7B30BFBB28509C40C11796F828C59A28E75B0C03712A2527 | Rating Details |
| 2023-01-22 20:53:39 -0600 | 06AC3CC6D8E3F0D9CE5278993FC86B9C07450593C3C320DC676D99392F5B38B2 | Rating Details |
| 2023-01-22 18:43:42 -0600 | 0D961034E6B3A7D8015EE1FA338C05A96670186CFA7C64BD38C6178692F1398B | Rating Details |
| 2023-01-23 15:30:35 -0600 | 17728731CCFCDF2DEAF9944F2BEDBF3E8B49814E878D73627FDA5A2DB529A832 | Rating Details |
| 2023-01-23 07:31:05 -0600 | 17FC9A86B53584287A4CCB0473F7FC301803266886168B8457FC8DD53F5CCB1A | Rating Details |
| 2023-01-22 21:54:43 -0600 | 1AB1C6FD0101C9CE62689B76F32560C146AA3FA6B4AB694986267F981A37FD67 | Rating Details |
| 2023-01-22 15:42:41 -0600 | 3440E327FFC09396E77E3C806B2CE63500A27905ABDA4DA599C2EFB3935307B4 | Rating Details |
| 2023-01-23 01:39:47 -0600 | 35282A98512DB4D41E595CA3C2592FA57A7D4BBB2637F906CE84DB32C27C5FB4 | Rating Details |
| 2023-01-22 16:55:40 -0600 | 387B98AAFA8F6C8EC70FC5863695018284889BE15A31C157FC07ECCFE3A17057 | Rating Details |
| 2023-01-23 12:25:48 -0600 | 39300997B1E6B9A374476B2425433EB97CE1B66D5675D53AC363A45CF0E63303 | Rating Details |
| 2023-01-23 15:01:55 -0600 | 39D18D9DBF376F31669F4BB648CF0242787FE31478EDB4EFF7C71774358F302C | Rating Details |
| 2023-01-22 22:21:48 -0600 | 3BEDD149E64ED044B457CDC6F49765E5670FBD15D82D61742CE91E25C7451118 | Rating Details |
| 2023-01-23 07:23:42 -0600 | 3E43C30DFEEF19A4BA0EFE1E78A730455FA07A446BE71F2B8324CB307921EAB8 | Rating Details |
| 2023-01-22 20:58:10 -0600 | 44E5381722F723C4B45DE5B3BA2B9C3EDDBF397ECDB2E6FA55A7198AC80332B1 | Rating Details |
| 2023-01-23 00:28:30 -0600 | 452675411251FF232955EE75BC7A129889056E868B6570E6370A8D995C38AC79 | Rating Details |
| 2023-01-22 15:48:23 -0600 | 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04 | Rating Details |
| 2023-01-23 06:22:25 -0600 | 467E0AD2F806345CC87E40E0E071B9977F6F1BAAF5B96D1BD9FF4847C00A1AA9 | Rating Details |
| 2023-01-23 08:26:12 -0600 | 4CFF19BD69F823E18A5AFBF5CD7648436BD1D8B0C02EBB4B6789AA19064063E0 | Rating Details |
| 2023-01-22 15:26:05 -0600 | 6CC8945A86394E266A0B9014D517EE1CB11C1604CDF481CD1DA94C2572AA63D8 | Rating Details |
| 2023-01-23 15:55:50 -0600 | 7E3FB87DC5EA876C31503289860B83D83BEB767468E70217E1B19405970CAF75 | Rating Details |
| 2023-01-22 21:14:23 -0600 | 91ED1050C69AB445CFA549CAAF55F48AAC56D267EAADDF024A57D453A99233C4 | Rating Details |
| 2023-01-22 21:56:34 -0600 | A2DC58CAC49F050F6B74F0D299C1D6B9DFA7FE27C697DDF6360E9CEB514255FD | Rating Details |
| 2023-01-22 14:08:23 -0600 | A32798EEEE1E44F0463D1319AC009549D2ED9B3CD1AF04B9825DFF932C0CAE7A | Rating Details |
| 2023-01-23 07:42:22 -0600 | C559E982739691E2EFE38F13A971AA3B8B28A962694A86631FB41C5B2274E6C4 | Rating Details |
| 2023-01-22 14:05:55 -0600 | D45A2C2D0A01452EB4CAC563989CA4D4828760FB2A92310BCB8E87CE1A83E5A9 | Rating Details |
| 2023-01-23 02:18:37 -0600 | E5F7BF0893CA44B7CFFEDF841F121C166766D07A7730EF9757E5BA6E5533B1CA | Rating Details |
| 2023-01-23 10:44:22 -0600 | E6653BBB4A52C0E835D22C362DB0DAC1E20A0B83C342C87F705FD3AE8DB25A65 | Rating Details |
| 2023-01-22 21:53:16 -0600 | F1C0EF8A7DDCA44C34FFC47CF004111075F3064D93C0747FFAB2CDFC7BF4768C | Rating Details |
| 2023-01-23 15:18:28 -0600 | F528AAAA88C4B132E802219BEA33EF12FFBE16B0DD0A5593F8C2E9387AA3D10F | Rating Details |
| 2023-01-23 07:50:24 -0600 | F74824CBC9B020AD6D6FC1CC3D7992D1049369A4BBB6E1D1043C3FC1F66AD863 | Rating Details |
| 2023-01-22 14:08:23 -0600 | Rating Details | |
| 2023-01-23 01:31:50 -0600 | Rating Details | |
| 2023-01-23 01:39:47 -0600 | Rating Details | |
| 2023-01-22 21:14:23 -0600 | Rating Details | |
| 2023-01-22 15:48:23 -0600 | Rating Details | |
| 2023-01-22 18:43:42 -0600 | Rating Details | |
| 2023-01-23 00:28:30 -0600 | Rating Details | |
| 2023-01-23 07:42:22 -0600 | Rating Details | |
| 2023-01-23 07:50:24 -0600 | Rating Details | |
| 2023-01-22 21:56:34 -0600 | Rating Details | |
| 2023-01-22 21:54:43 -0600 | Rating Details | |
| 2023-01-23 06:22:25 -0600 | Rating Details | |
| 2023-01-23 15:30:35 -0600 | Rating Details | |
| 2023-01-22 14:05:55 -0600 | Rating Details | |
| 2023-01-22 15:26:05 -0600 | Rating Details | |
| 2023-01-23 06:02:52 -0600 | Rating Details | |
| 2023-01-23 10:07:10 -0600 | Rating Details | |
| 2023-01-23 02:18:37 -0600 | Rating Details | |
| 2023-01-22 20:53:39 -0600 | Rating Details | |
| 2023-01-22 22:46:17 -0600 | Rating Details | |
| 2023-01-23 10:44:22 -0600 | Rating Details | |
| 2023-01-23 12:25:48 -0600 | Rating Details | |
| 2023-01-22 21:53:16 -0600 | Rating Details | |
| 2023-01-23 15:01:55 -0600 | Rating Details | |
| 2023-01-22 15:42:41 -0600 | Rating Details | |
| 2023-01-22 20:58:10 -0600 | Rating Details | |
| 2023-01-23 07:31:05 -0600 | Rating Details | |
| 2023-01-23 15:55:50 -0600 | Rating Details | |
| 2023-01-23 07:23:42 -0600 | Rating Details | |
| 2023-01-22 22:21:48 -0600 | Rating Details | |
| 2023-01-23 15:18:28 -0600 | Rating Details | |
| 2023-01-22 16:55:40 -0600 | Rating Details | |
| 2023-01-23 08:26:12 -0600 | Rating Details |